| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |